Hemat Onco Flashcards
(48 cards)
Döhle bodies (light blue, peripheral inclusions) due to left shift are seen in
Neutrophils
Platelets contain dense granules such as
Calcium, ADP, Serotonin, Histamine
Platelets contain alpha granules such as
vWF, fibrinogen, fibronectin, platelet factor 4
Macrophages naming varies by specific tissue type eg-
Osteoclasts in the bone, histiocytes in connective tissue
Lipid A from bacterial LPS binds CD14 on macrophages to initiate
Septic shock
Basophils mediate allergic reaction and contain granules like
Heparin (anticoagulant) and histamine (vasodilator)
Leukotrienes are synthesised and released on demand
Mast cells contain basophilic granules and mediate -
Local tissue allergic reactions
Mast cells are activated by tissue trauma, C3a and C5a, surface IgE cross linking by antigen (IgE receptor aggregation) and cause
Degranulation and release of histamine, heparin, tryptase and eosinophil chemotactic factors
Cromolyn sodium prevents
Mast cell degranulation (used in asthma prophylaxis)
Vancomycin, opioids, radiocontrast dye can elicit
IgE-independent mast cell degranulation
CD56, CD16 (FcR)
NK cells
CD4+ helper T cells are the primary target of
HIV
Neutrophil lysosomes (Azurophilic granules) contain
Proteinases, acid phosphatases, myeloperoxidase, B glucuronidase
Neutrophil chemotactic agents
C5a, IL 8, LTB4, 5 HETE, Kallikrein, platelet activating factor, bacterial proteins
Aspirin irreversibly inhibits COX, thereby inhibiting
TXA2 synthesis
What drugs inhibit ADP-induced expression of GpIIb/IIIa by blocking P2Y12 receptor
Clopidogrel, Prasugrel and Ticagrelor
Abciximab, Eptifibatide, Tirofiban
Inhibit GpIIb/IIIa directly
Risocetin activates
vWF to bind GpIb
Failure of aggregation with Risocetin assay occurs in
von Willebrand disease and Bernard-Soulier syndrome
Desmopressin promotes the release of
vWF and factor VIII from endothelial cells
Drug induced hemolytic anemia caused by
Penicillins, Cephalosporins, NSAIDS
Drug induced hemolytic anemia caused by
Penicillins, Cephalosporins, NSAIDS
Acute intermittent porphyria
Affected enzyme: Porphobilinogen deaminase
Accumulated substrate: Porphobilinogen, ALA
Treatment: Hemin and glucose
Porphyria cutanea tarda
Affected enzyme: Uroporphyrinogen decarboxylase
Accumulated substrate: Uroporphyrin (tea coloured urine)
Treatment: Sun avoidance, Hydroxychloroquine